Surveillance of antimicrobial susceptibility of urinary pathogens in a tertiary care hospital.
Arya
Subhash C
SC
Agarwal
Nirmala
N
Agarwal
Shekhar
S
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002442:Ceftazidime / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*; D004927:Escherichia coli Infections / Q000453:epidemiology; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007194:India / Q000453:epidemiology; D007710:Klebsiella Infections / Q000453:epidemiology; D008826:Microbial Sensitivity Tests; D011512:Proteus Infections / Q000453:epidemiology; D011552:Pseudomonas Infections / Q000453:epidemiology; D012189:Retrospective Studies; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D002442:Ceftazidime